Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin.


The mechanisms underlying prostate cancer progression are poorly understood. Proteins responsive to androgens may be involved in the development and progression of prostate cancer and the ultimate failure of androgen-ablation therapy. Therapy with somatostatin (sms) analogues could be a possible therapeutic alternative to chemotherapy in hormone refractory… (More)


6 Figures and Tables

Slides referencing similar topics